In Silico Experimental Modeling of Cancer Treatment by Trisilowati, & Mallet, D. G.
International Scholarly Research Network
ISRN Oncology
Volume 2012, Article ID 828701, 8 pages
doi:10.5402/2012/828701
Review Article
InSilico ExperimentalModelingof Cancer Treatment
Trisilowati1 andD.G.Mallet1,2
1Mathematical Sciences Discipline, Queensland University of Technology, P.O. Box 2434, Brisbane, QLD 4001, Australia
2Institute of Health and Biomedical Innovation, Queensland University of Technology, P.O. Box 2434, Brisbane, QLD 4001, Australia
Correspondence should be addressed to D. G. Mallet, dg.mallet@qut.edu.au
Received 21 September 2011; Accepted 28 October 2011
Academic Editors: A. M. Garcia-Lora, F. Kuhnel, and M. Stracke
Copyright © 2012 Trisilowati and D. G. Mallet. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
In silico experimental modeling of cancer involves combining ﬁndings from biological literature with computer-based models of
biological systems in order to conduct investigations of hypotheses entirely in the computer laboratory. In this paper, we discuss
the use of in silico modeling as a precursor to traditional clinical and laboratory research, allowing researchers to reﬁne their
experimental programs with an aim to reducing costs and increasing research eﬃciency. We explain the methodology of in silico
experimentaltrialsbeforeprovidinganexampleofinsilicomodelingfromthebiomathematicalliteraturewithaviewtopromoting
more widespread use and understanding of this research strategy.
1.Introduction
Traditional laboratory-based cancer research involves expen-
sive trial and error experimental strategies applied to hu-
mans, animals, and their harvested tissues. “In silico experi-
mentation,” the coupling of current computing technologies
with mathematical or theoretical characterizations of cancer
cell biology, provides a novel approach to guiding the early
stages of hypothesis development and experimental design
that has the potential to create subsequent eﬃciencies and
cost savings in the laboratory. This computational approach
is advantageous because it allows vast numbers of experi-
mentstobecarriedoutthatareeasilyobservedatanydesired
level of detail and can be repeated and controlled at will.
It seems diﬃcult to argue that preclinical studies in can-
cer biology are expensive. Such studies involving in vitro and
in vivo animal experiments involve hypothesis generation
and testing to determine whether further trials are warranted
and are extremely costly both in terms of researchers’ time
and the associated ﬁnancial investment. Costs, such as labo-
ratory setup, equipment and space, time spent by academics
training others, and the time, equipment, and materials costs
involved in repetitive, hands-on experimental work, all con-
tribute to the expense of laboratory-based experimental re-
search.
Our contention in this paper, a view shared by many
researchers in the closely related ﬁelds of computational,
theoretical and mathematical biology, is that in silico experi-
ments can be used as precursors to, or in combination with,
preclinical experimental studies to provide guidance for the
development of more reﬁned hypotheses and experimental
studies. In silico and mathematical modeling lends itself to
the determination of preliminary information such as toxi-
city, pharmacokinetics, and eﬃcacy, which can then be used
to guide preclinical and clinical studies.
In silico experimentation involves the combination of
biological data and expert opinion with mathematical and
computer-based representations to construct models of bio-
logy. Computer-based experiments can then be carried out
using these models rather than, or in combination with, lab-
oratory research. Using parameter distributions based on
current expert opinion (“fuzzy” inputs) or actual biological
data (random variables) as inputs into the in silico models,
it is possible to create what are eﬀectively “computational
patients” upon which to experiment. It is of course also pos-
sible to consider smaller-scale experiments and even mul-
tiscale experiments, conducted on molecular, cellular, and
tissue/organ levels. Appropriate use of in silico models in-
volves making predictions based on experimental data and
expert information and allows the models to be eﬀectively2 ISRN Oncology
used to inform clinical trials with a view to reducing costs
and increasing eﬃciency.
To provide an example, consider the study of cell transfer
therapy for metastatic melanoma patients of Rosenberg
et al. [1]. The authors commented on the diﬃculty of deriv-
ing meaningful results from human experiments because of
the variations in cell types, tumor types, immune states, and
more fundamentally the human subjects themselves. While
Rosenberg et al. suggest a solution to such a problem is to
treat the same patient in diﬀering ways over a period of time,
anothermoreethicalandﬂexible,andlesshazardousmethod
is through the use of in silico models and experimentation.
This approach was used in the model discussed in Section 3.
There is a rich history of theoretical studies involving
mathematical and computational approaches to studying
cancer. Burton and Greenspan pioneered the mathematical
m o d e l i n go ft u m o rg r o w t hw i t hm o d e l so fg r o w t hd y n a m i c s
explained as a problem of diﬀusion [2–5]. Since that time,
theoretical studies of most aspects of tumor growth and re-
lated processes have been investigated at least to some extent,
using various diﬀerent methodologies including diﬀerential
equations, stochastic models, and cellular automata. Araujo
and McElwain provide an excellent review of the mathemati-
calmodelingworkcarriedoutuptomiddleofthelastdecade
[6]. More recently, Alarc´ on et al. [7], Mallet and coworkers
[8,9],andFerreiraetal.[10,11]haveusedanewparadigm—
that of spatiotemporal, stochastic models using hybrid cel-
lular automata techniques—to represent “computational pa-
tients”or“insilicoexperiments”inanewdirectionforcancer
research.Thisexperimentalparadigmextendsthetraditional
mathematical modeling of cancer to incorporate computa-
tional simulations that are parameterized in such a way to
represent diﬀerent patients or diﬀerent experiments.
It is also becoming more common to ﬁnd mathematical
studies appearing in the cancer literature. Utley et al., for ex-
ample, discuss improvement in survival rates resulting from
postoperative chemotherapy for lung cancer patients [12].
They note that the marginal (5%) survival rate improvement
due to chemotherapy may be outweighed for some patients
by the morbidity due to the treatment and that further trials
do not actually improve information provided to patients,
but rather improve the certainty of that prediction. Utley
et al. propose the use of a mathematical model, utilizing pa-
tient-speciﬁc pathological cancer stage data combined with
existingtechniques,toarriveatbetterevidenceforinforming
patients regarding their postoperative treatment choices.
In a study more at the preclinical stage of research, de
Pillis et al. describe a diﬀerential equation-based model for
theinteractionsbetweenagrowingtumor,naturalkillercells,
and CD8+ T cells of the host immune system [13]. With
a view to understanding how the immune system assists in
rejecting growing tumors, de Pillis et al. present mathemati-
cal descriptions of key mechanisms in the immune response
before ﬁtting the model to data from published mouse and
human studies. A parameter sensitivity analysis reveals the
key role of a patient-speciﬁc variable and that the model may
in fact provide a means to predict positive response of par-
ticular patients to treatment.
Mallet and de Pillis [8] and later de Pillis et al. [9]e x -
plored a particular type of in silico model known as a hybrid
cellular automata-partial diﬀerential equation (CA-PDE)
model to describe the interactions between a growing tumor
and the host immune response. A hybrid CA-PDE model
combines the traditional continuum methods of applied
mathematics, such as macroscale reaction-diﬀusion equa-
tions describing chemical concentrations, with more mod-
ern,individual,orgrid-basedautomatonmethods,whichare
used for describing individual cell-level phenomena. The
hybrid CA-PDE modeling approach has been successfully
used in the past to model tumor growth, chemotherapeutic
treatment, and the eﬀects of vascularization on a growing
tumor [7, 10, 11, 14]. In Section 3 we discuss this model in
some detail, explaining how the model is constructed as well
as typical outputs of an in silico model of this type.
2. Methods—In Silico Trials
While in vitro and in vivo models use actual biological ma-
terials and/or actual animals to investigate hypotheses and,
for example, predict eﬀectiveness of treatment strategies, in
silico models use speciﬁcally designed computer programs to
mimic these “real” experimental environments and to con-
duct computational experiments. There exist a number of
diﬀerent types of in silico model including diﬀerential equa-
tionmodelsthattrackchangesinquantitiesovertimeand/or
space, network models that trace lines of probabilistic causa-
tion and/or correlation, discrete cellular automata- or indi-
vidual-based models, and hybrids of all of these models.
Rather than providing models of real biological phenomena
a n ds t r u c t u r e st h a th a v eab a s i si ns o m es o r to fe x t r a c t e d
tissue or a somehow related animal species, these in silico
models are comprised of mathematical and computational
representations such as formulae, equations, and/or com-
puter programs. A key feature of such models is that they can
be “parameterized” so that quantities or rates not known in
the real world or which are speciﬁc to diﬀerent experiments
can be investigated via computational experiments, or as we
dub them “in silico trials.” The concept of the in silico trial
can be thought of as akin to clinical trials. Just as each patient
in a clinical trial has their own set of characteristics such as
height, age, and status with regard to smoking and alcohol
consumption so too we can run the program of an in silico
model multiple times with varied parameters to produce
“computational patients” in an in silico trial.
The development of in silico model is often a process
of cross-disciplinary collaboration between cancer biologists
and mathematicians or modelers. Generally, the initial stages
involve the model builder obtaining an understanding of the
tumor biology required for developing the in silico model.
This will be a period of intense collaborative work involving
discussions between all investigators and a review of the the-
oretical and experimental literature. The next stage involves
abstraction of biological information into a mathematical or
computational form, that is, building the update rules. This
requires the creation of mathematical representations of
relevant micro level biological phenomena and mecha-
nisms (such as rates and results of cell division, methods forISRN Oncology 3
representing distributions of chemical molecules, and inter-
actionsbetweenantigenandantigenpresentingcells)andthe
compilation of these into a macrolevel description of the real
experimental situation.
Following the development of the update rules, the algo-
rithm for the entire process is computerized usually employ-
ing generic programming languages such as C++ or with
mathematical software such as MATLAB. This algorithm
allows for the solution of the in silico model and facilitates
easy simulation of large numbers of experiments, that is, re-
peated simulation of the model using many diﬀerent param-
eter sets in order to mimic running slightly diﬀerent exper-
iments in the laboratory. This could reﬂect, for example, an
investigationoftheeﬀectofdiﬀerentquantitiesofgoldnano-
particles on eﬀectiveness of radiotherapy or the eﬀect of dif-
ferent concentrations of chemotherapeutic treatments.
While largely automated via the computer program, the
simulation of the in silico model requires careful and contin-
uous monitoring to ensure that computations converge (i.e.,
solutionsareobtainedratherthancomputationalerrors)and
tomakeadjustmentstoinvestigationswhenresultsofinterest
are observed.
Following simulation of the in silico model, the results
of the computational experiments are analyzed and inter-
preted. This generally involves the use of custom-designed
visualization of the resulting data. The investigators use the
outputs of the model to determine what results are already
useful for informing any associated experimental studies as
well as what parts of the in silico model are deﬁcient and re-
quire reﬁnement along with a follow-up round of in silico
experiments. Thewholeprocesscanbe repeated,withreﬁne-
ment, as often as new information is required, and in general
the costs of follow-up in silico experimentation decrease as
the fundamental computational framework has already been
developed. In the remainder of this section, we present an
oversimpliﬁed and generic model along with the computa-
tional algorithm to further illuminate this concept.
2.1. The CA Approach. A cellular automaton (CA) is a type
ofmathematicalmodel,discreteinbothspaceandtime.Here
we consider a two-dimensional CA, such as that which could
be used to model the surface of the skin or possibly a petri
dish, but note that three-dimensional models are simple, if
computationally expensive, extensions of the same concepts.
A two-dimensional CA consists of a lattice or grid of CA
elements covering a region of space (see Figure1). Applied in
the biological context, each element is allowed to house one
or more biological cells and, depending on the experimental
situation being modeled, may also hold other matter such
as molecules, debris, ﬂuid, or bacteria. The cells in the CA
elements are allowed to interact with one another via update
rules. The set of update rules deﬁnes how the state of each
element changes in response to its current state and the cur-
rent state of its neighbors—the deﬁnition of these rules is the
fundamental modelling stage in the development of the in
silico model (see Figure 2). The accuracy of the model is
heavily dependent on designing rules that adequately reﬂect
the real interactions between cells.
The type of cellular automata model considered here is
executed as follows. The system is ﬁrst initialized so that the
computational representation presented in the cellular auto-
mata grid matches some initial condition for the ensuing
computational experiment. Next, a sequence of “time steps”
is carried out such that the model time is incremented by
a small amount at each step. Within each time step, every
spatial location or element in the CA grid is investigated to
identify its contents. Depending on the contents, an appro-
priate update rule is applied which may involve the states of
the neighboring elements. Updates are made throughout the
grid, time is incremented, and the process continues.
Toextendthismodeltoallowinsilicotrials,thecomputer
program for the algorithm described in the above paragraph
is wrapped in a further program. This involves providing a
collection of two or more (depending on the number of ex-
perimentsortrialsrequired)parametervaluesetstothealgo-
rithm and running the algorithm once with each set. The
output data, for example, cell counts over time, for each trial
is exported to memory at the completion of each trial.
2.2. Development of Rules. As mentioned earlier, with regard
to developing an accurate description of the biological proc-
ess of interest, the speciﬁcation of the update rules for a cel-
lular automata-based in silico model is the most important
part of the modelling process. To demonstrate this, consider
the seemingly simple case of the movement of one cell to a
neighboring location and the following increasingly complex
but increasingly accurate rules.
Rule 1. IfthereisoneormoreemptyCAelementssurround-
ing a cell, move to a randomly chosen empty element, other-
wise, do not move.
Rule 2. IfthereisoneormoreemptyCAelementssurround-
ing a cell and moving to one would increase the cell’s satis-
faction in some way, move to a randomly chosen element of
this type, otherwise, do not move.
Rule 3. IfthereisoneormoreemptyCAelementssurround-
ing a cell, consider moving to one of these locations with
a probability that depends on factors such as cell adhesion
levels, nutrient supply, and chemoattractants, otherwise, do
not move.
Each of these rules could be implemented in an in silico
model as the determining factor regarding whether or not a
cellmoves.ClearlymovingfromRule1toRule3,theamount
of realism increases, but, simultaneously, the amount of
information required to design the rule also increases. Rule 1
doesnotrequireanyinformationaboutthecellsofinterest—
the cell simply moves if it can, and the location it moves to is
randomlychosen.Ontheotherhand,Rule3requiresthatthe
modeler has some preexisting or obtainable understanding
regarding how cells respond to chemoattractants, how cell
adhesion aﬀects motility, and what impact nutrient levels
have on the decision of a cell to move from location to loca-
tion. Thus we note that with more information about the bi-
ological process, the modeler can construct more realistic4 ISRN Oncology
Figure 1: A two-dimensional grid is imposed on a region of space of interest with cells of diﬀerent types, molecules, debris, ﬂuid, and/or
bacteria housed in each element of the grid.
Current state Update function Next state
State of neighbours
Figure 2: The transition from the current state to the next state for each element of the CA grid is determined only by its current state, that
of its neighbors and the update rule.
update rules, but at the same time, a lack of information by
no means rules out insilicomodeling. Infact,insilicomodels
can yield rich information when they are used from the very
earlystagesaspartofhypothesisgenerationandtestingwhen
there is a dearth of biological information.
3.AnExample inCancerBiology
Mallet and de Pillis [8] presented a so-called “hybrid cellular
automata model” of the interactions between the cells of a
growing tumor and those of the host immune system. Mallet
and de Pillis successfully designed a computational method
for investigating the interactions between an idealized host
immune system and a growing tumor. The simulated tumor
growth experiments were found to be in qualitative agree-
ment with both the experimental and theoretical literature.
It was found that even with quite simple mathematical des-
criptions of the biological processes and with an overly sim-
pliﬁed description of the host immune system, the compu-
tational model had the potential to produce the behavior
observed in laboratory experiments including spherical and
papillary tumor growth geometries, stable and oscillatory
tumor growth dynamics, and the inﬁltration of the tumor
by immune cells. It was also possible to show the dependence
of these diﬀerent morphologies on key model parameters re-
latedtotheimmuneresponse.Numericalsolutionsproduced
using the Mallet and de Pillis model agreed qualitatively with
the experimental results demonstrated by Zhang et al. [15],
Schmollinger et al. [16], and Soiﬀer et al. [17].
While a laboratory model is usually designed to focus on
a particular stage of a process or a speciﬁc event, in silico
models canbedesignedtofocusonarbitrarilysmallorlarge-
scale phenomena. Mallet and de Pillis chose to focus on the
early stages of tumor growth during which the tumor is ad-
jacent to, but not yet inﬁltrated by, nutrient supplying vas-
culature in order to allow for an investigation of the initial
interactions between the immune system and the emerging
tumor. The simple model incorporated a simpliﬁed immune
system comprised of two cell types, namely, the natural killer
(NK) cells of the innate immune system and the cytotoxic T
lymphocytes(CTLs)ofthespeciﬁcimmunesystem.Ahybrid
cellular automata and partial diﬀerential equation model
was constructed with an aim to demonstrate the combined
eﬀects of the innate and speciﬁc immune systems on the
growth of a two-dimensional representation of a growing tu-
mor. This was accomplished by constructing a model with
computerized cell behaviors built from descriptions in the
experimental literature and ﬁndings of dynamic models of
tumor—immune system interactions developed in the theo-
retical literature such as the work of Kuznetsov and Knott
[18] and de Pillis and Radunskaya [19, 20].ISRN Oncology 5
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Figure 3: An example of growth curve produced by the Mallet and
de Pillis in silico model showing total number of tumor cells over
time for a tumor growing in the absence of immune response.
Mallet and de Pillis’ hybrid cellular automata model em-
ployed a coupled deterministic-stochastic approach that had
the beneﬁt of being conceptually accessible as well as compu-
tationally straightforward to implement. The authors used
reaction-diﬀusion equations, to describe chemical species
such as growth nutrients, and a cellular automata strategy to
track the tumor cells and two distinct immune cell species.
Together, these elements simulated the growth of the tumor
and the interactions of the immune cells with the tumor
growth.
The model tracked cells both through time and through
space—a clear advantage over dynamic models that assume
a spatially well-mixed population of cells, which is not often
the case in reality. Unlike continuum-based spatiotemporal
models, which are generally comprised entirely of partial dif-
ferential equations, the hybrid cellular automata approach
allows for the consideration of individual cell behavior and
associated randomness, rather than applying a general rule
to a collection of cells, as is the case with continuum models.
The cellular automata approach is also very ﬂexible in terms
of its computational implementation. While the Mallet and
dePillismodelconsideredonlyfourcellspecieswithanover-
ly simplistic view of the immune system, it is easily modiﬁed
to cater for the inclusion of more cell types or new chemical
species.
The evolution of the cell species considered in the Mallet
and de Pillis model proceeds according to a combination of
probabilistic and deterministic rules, developed in an at-
tempt to describe the phenomena considered important in
the theoretical model. In particular, Mallet and de Pillis
imposed a simplifying assumption to the host cells such that,
other than their consumption of nutrients, they allow tumor
cells to freely divide and migrate and were more or less
passivebystanderstotumorgrowth.Tumorcellsontheother
handwereabletomove,divide,dieduetonutrientlevelsand
die because of the immune response, each with a probability
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Figure 4: An example of two-dimensional tumor growth after 800
cell cycles, simulated using the Mallet and de Pillis in silico model.
Red intensity indicates tumor cell density. The domain shown is
approximately 10–20mm square, and growth is over a time period
of at least a year.
that depended on some combination of nutrient levels, local
immuneresponse,andcrowdingduetothepresenceofother
tumor cells. Natural killer cells were maintained at or near a
“normal” level by recruitment from outside the domain of
interest whenever the local density dropped too far below its
equilibrium level. Both natural killer cells and cytotoxic T
cells were able to lyse tumor cells, although CTLs could do
so more than once and were able to attract other CTLs to the
local area. CTLs were also subject to removal from the local
region with a probability depending on the local tumor cell
density.
The rules used to represent these phenomena are devel-
opedasapproximationsofrealityandinvolveconsideringin-
dividual events, such as an interaction between a cell on the
periphery of a tumor and a natural killer cell, and attempting
to quantify what happens as a result of this interaction. This
act of quantifying is guided by accepted results in the exper-
imental and theoretical literature, expert elicitation, and
simple physical arguments. As mentioned in the previous
section,thedevelopmentoftheserulesisthemostimportant
step in model development.
While the design and statement of all the CA rules are
presentedintheoriginalpaper,hereweexpandonthedesign
of one of the rules to elucidate how such objects are con-
structed. Take, for example, the individual cell level event of
cell division. This process is extremely complex and involves
countless subprocesses each with many participants. Just as
an experimentalist in the laboratory does not consider each
of these explicitly, we do not attempt to represent each of
them in the computational model either. Instead, we distil
what information is available in the literature and from col-
laborators to arrive at a model representation of the chance
that the event occurs given certain conditions. This distilled
model representation is the cellular automata rule.
For the case of cell division, Mallet and de Pillis consider
that given a tumor cell, the probability of division increases
with the ratio of nutrient concentration to the number of tu-
mor cells already present in the local region. Note that there6 ISRN Oncology
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Figure 5: Two-dimensional snapshots of a tumor exhibiting high levels of necrosis (a) and populations of immune cells that have inﬁltrated
the tumor mass causing cell death (b).
is no mention of subcellular signal processing and neither
is there any consideration of macrolevel pressure ﬁelds.
Instead, the chance of the occurrence of a cell division is con-
densed into a consideration of whether or not there are suf-
ﬁcient nutrients nearby and whether or not the region is al-
ready crowded with tumor cells.
This rule is interesting because it also incorporates a sec-
ond subrule—that of the placement of the daughter cell.
The model dictates that the grid location upon which the
daughter cell is placed depends upon the cells occupying the
neighborhoodofthemothercell.Forexample,adividingcell
with at least one host cell or necrotic space surrounding it
will place its daughter cell randomly in one of those noncan-
cerous locations and either destroy the host cell or simply
replace the necrotic material. On the other hand, if all ele-
ments around the dividing cell are ﬁlled with tumor cells, the
daughter cell will be placed in the neighboring element con-
tainingthefewesttumorcells.Theauthorsviewedthisasone
approach to modeling tumor cell crowding.
In silico models such as that of Mallet and de Pillis can
produceanarrayofdiﬀerentoutputs.Inthisparticularwork,
the authors focused on presenting growth curves and two-
dimensionalspatialsnapshotsintimeofgrowingtumorsthat
were compared with experimental results. Figures 3 and 4,
for example, show a growth curve and two-dimensional
snapshot of a tumor growing in the absence of the immune
system.Thisresultwasusedasabaselinetocomparewithex-
perimental and previous mathematical results prior to in-
vestigating the eﬀects of the immune system with this new
model. Note, in Figure 3, the initially exponential growth
phase (cycle 0–200), before a phase of linear growth (cycle
200–800). These growth characteristics mimic the growth
rates described in the experimental work of Folkman and
Hochberg [21] and mathematically by Greenspan [3]. Figure
4isasnapshotintime(800cellcycles)ofthesamesimulation
where we see a roughly circular tumor with a radius of about
200 cells growing steadily outward toward the sources of the
nutrient. Higher tumor cell densities are seen at the periph-
ery of the tumor while in the center, a necrotic core is begin-
ning to form with some necrotic material already appearing.
Mallet and de Pillis also presented a particularly inter-
esting application of their model that produced qualitatively
similar simulated tumors to the results of some recent ex-
perimental studies of immune response to tumor growth.
The experimental studies of Schmollinger et al. [16], Soiﬀer
et al. [17], and Kuznetsov and Knott [18] discussed the rela-
tionship between increased survival rates of cancer patients,
tumor necrosis, and ﬁbrosis, and the presence of intratu-
moral T cells or inﬁltrated T lymphocytes. In Figures 5(a)
and 5(b), immune cells are shown to have inﬁltrated a grow-
ing tumor. In particular, the darker regions in Figure 5(a) are
evidence of tumor necrosis while lighter regions of Figure
5(b) are indicative of high immune cell populations. These
solution plots are similar to experimental results shown by
Schmollingeretal.[16],Soiﬀeretal.[17],andKuznetsovand
Knott [18]wherestringsofimmunecellsaremovingintothe
tumor, surrounding individual cells, and causing tumor cell
necrosis.
Thesimulationresultsshowedemployeeparametersfora
compact tumor (in the absence of the immune system), low-
level CTL recruitment, and low CTL death probability. We
emphasize again that the same computer program is used
to implement these simulations as those considered in the
previous ﬁgures; varying system parameters is all that is re-
quired to consider quite a diﬀerent experiment when using
the in silico modeling technology.
The example of an in silico model presented in this sec-
tion employed a moderately complex, hybrid cellular auto-
mata-partial diﬀerential equation methodology to describe
interactions between the host immune system and a growing
tumor. In the absence of a simulated immune system, the
model was capable of reproducing both compact-circular
andwildpapillarytumormorphologies.Morphologychange
wasdirectlyrelatedtotherelativeratesofconsumptionofthe
survival and mitosis nutrients by both tumor and host tissue
cells, and the results presented correspond qualitatively with
the experimental literature (such as Folkman and Hochberg
[21]). When the model allowed for a simulated immune
system, with diﬀerent choices of T-lymphocyte recruitment
and/or death parameters, oscillatory growth curves wereISRN Oncology 7
observed for nearly all parameter sets. Depending on the
strength of the immune system recruitment and death para-
meters, the tumor growth either increased without bound or
resultedindestructionoftheinvasivegrowth.Themodelwas
also able to reproduce experimentally observed immune cell
inﬁltration of growing tumors.
The diﬀerent sets of parameter values used in the simula-
tion of the Mallet and de Pillis model are the primary meth-
od for computationally mimicking diﬀerent strengths of im-
mune systems of, for example, healthy individuals, capable
of early tumor detection and destruction, and individuals in
poor immune health, for whom tumors grow easily. In sum-
mary, even though the update rules proposed in the Mallet
and de Pillis model were relatively simple and the number
of cell types considered was far from exhaustive, the authors
created an in silico model that was able to produce results
in qualitative agreement with both the experimental and
theoretical literature and which could be improved upon
to provide useful preclinical results of relevance for further
model development for guiding experimental work related
to various treatment and vaccination strategies.
4. Conclusions
In silico experimentalmodelingofcancerinvolvescombining
ﬁndings from biological literature with computer-based
models of biological systems in order to conduct investiga-
tions of hypotheses entirely in the computer laboratory. In
this paper we have presented a discussion of the concept of
insilicomodeling and how insilicomodels are constructed in
p r a c t i c e .W eh a v ep r e s e n t e da ne x a m p l eo fin silico modeling
that is relevant to the study of cancer and discussed its appli-
cation and use as a hypothesis-generating tool as a precursor
to or in combination with traditional clinical and laboratory
research. This type of computational tool, when used in
transdisciplinary research teams, has the potential to allow
researchers to reﬁne their experimental programs with an
aim to reducing costs and increasing research eﬃciency, and
we advocate increased use of such strategies by research
groups.
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